August Digital JIC Bonus Content Delivered to your Mail Interactive Editorial and Advertisements
View the August Issue	Subscribe NOW!

CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence A Complimentary CME Accredited Lunch Symposium Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115 Click Here for More Info. This activity is supported by an educational grant from Bracco Diagnostics Inc.

PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Archived Accredited Webcast Click Here for More Info. This activity is supported by an educational grant from Baxter Healthcare Corporation.

NEWEST PERSPECTIVES ON DRUG-ELUTING STENTS Complimentary Accredited Web Archive Release Date: June 10, 2008 Expiration Date: June 10, 2009 This activity is supported by an educational grant from Abbott Vascular.

---

Hemostasis Management in Today’s Cath Lab Complimentary Accredited Web Archive Complimenty Accredited Web Archive Release Date: June 19, 2008 Expiration Date: June 19, 2009 This activity is supported by an educational grant from Radi Medical Systems, Inc.

---

Recent Advances in Cardiac PET and CT Angiography for the Management of Patients with Coronary Artery Disease Complementary Web Cast Release Date: January 4, 2008 Expiration Date: January 4, 2009 Target Audience: Physicians and nuclear medical technologists This activity is supported by an educational grant from Bracco Diagnostics Inc..

---

CONTRAST MEDIA USE IN HIGH-RISK PATIENTS: THE LATEST DATA Archived Webcast Release: 3-21-08 Expiration Date: 3-21-09 Target Audience: Physicians, nurses, and technologists This activity is supported by an educational grant from Bracco Diagnostics Inc.

---

COMPLIMENTARY Web Cast Adjunctive Phararmacology For The Cath Lab ON DEMAND A Complimentary Web Archive Release Date: December 7, 2007 Expiration Date: December 7, 2008 This web cast contains 3 different modules

COMPLIMENTARY On Demand Webcast Infection Prevention for Minimally Invasive Interventions:

ORIGINAL CONTRIBUTIONS: Risk of Late-Acquired Incomplete Stent Apposition after Drug-Eluting Stent versus Bare-Metal Stent. A Meta-Analysis from 12 Randomized Trials

Drug-eluting stents (DES) have demonstrated the capacity to reduce binary angiographic restenosis, and the need for subsequent revascularization procedures of the target vessel. Serial intravascular ultrasound (IVUS) studies have demonstrated that DES dramatically reduce the degree of neointimal hyperplasia compared to bare metal stent (BMS). DES do not increase the risk of stent thrombosis in comparison with BMS during the first year after stent implantation, at least under prolonged double antiplatelet therapy. Conversely, long-term follow up of randomized trials have shown that DES seem to increase the risk of stent thrombosis more than 1 year after implantation (very late stent thrombosis), but the reasons have not been elucidated yet.